Prodrugs of Peptides. 6. Bioreversible Derivatives of Thyrotropin-Releasing Hormone (TRH) with Increased Lipophilicity and Resistance to Cleavage by the TRH-Specific Serum Enzyme
- 1 January 1990
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 07 (9) , 885-892
- https://doi.org/10.1023/a:1015933504191
Abstract
Bioreversible derivatization of TRH (pGlu–His–Pro–NH2) to protect the tripeptide against rapid enzymatic inactivation in the systemic circulation and to improve the lipophilicity of this highly hydrophilic peptide was performed by N-acylation of the imidazole group of the histidine residue with various chloroformates. Whereas TRH was rapidly hydrolyzed at its pGlu–His bond in human plasma by a TRH-specific pyroglutamyl aminopeptidase serum enzyme, the N-alkoxycarbonyl derivatives were resistant to cleavage by the enzyme. On the other hand, these derivatives are readily bioreversible as the parent TRH is formed quantitatively from the derivatives by spontaneous hydrolysis or by plasma esterase-catalyzed hydrolysis. In addition to protecting the parent TRH against rapid inactivation in the circulation and hence potentially prolonging the duration of action of TRH in vivo, the N-alkoxycarbonyl prodrug derivatives were much more lipophilic than TRH as assessed by octanol–buffer partitioning. This property may enhance prodrug penetration of the blood–brain barrier and various other biomembranes compared to the parent peptide.This publication has 35 references indexed in Scilit:
- Inhibitors of TRH-Degrading EnzymesAnnals of the New York Academy of Sciences, 1989
- Prodrugs of Peptides IV: Bioreversible Derivatization of the Pyroglutamyl Group by N-Acylation and N-Aminomethylation to Effect Protection against Pyroglutamyl AminopeptidaseJournal of Pharmaceutical Sciences, 1989
- Degradation and biological inactivation of thyrotropin releasing hormone (TRH): regulation of the membrane-bound TRH-degrading enzyme from rat anterior pituitary by estrogens and thyroid hormonesBiochimie, 1988
- Neuropeptide-specific peptidases: Does brain contain a specific TRH-degrading enzyme?Life Sciences, 1986
- Pharmacology of Thyrotropin-Releasing HormoneAnnual Review of Pharmacology and Toxicology, 1986
- Delineation of a Particulate Thyrotropin‐Releasing Hormone‐Degrading Enzyme in Rat Brain by the Use of Specific Inhibitors of Prolyl Endopeptidase and Pyroglutamyl Peptide HydrolaseJournal of Neurochemistry, 1986
- Regulatory peptides as a source of new drugs — the clinical prospects for analogues of TRH which are resistant to metabolic degradationBrain Research Reviews, 1982
- Thyrotropin-Releasing HormoneNew England Journal of Medicine, 1982
- Specificity of a Serum Peptidase Hydrolyzing Thyroliberin at the Pyroglutamyl‐Histidine BondEuropean Journal of Biochemistry, 1981
- Blood level and brain distribution of thyrotropin-releasing hormone(TRH) determined by radioimmunoassay after intravenous administration in rats.Journal of Pharmacobio-Dynamics, 1980